ADVANCED MALIGNANT TUMORS
Clinical trials for ADVANCED MALIGNANT TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug TQB3142 enters first human tests
Disease control Recruiting nowThis early-stage trial tests a new drug called TQB3142 in 66 adults with advanced tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers will also measure how the drug moves through the body and look f…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug combo takes on tough cancers in early trial
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called BMS-986488, alone or combined with other cancer drugs, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. About 437 adults w…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New cancer drug SPGL008 enters first human tests
Disease control Recruiting nowThis early-stage trial is testing a new biologic drug called SPGL008 in 96 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to find a safe dose and check for side effects. The drug is given either through a vein or under the skin. This i…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New 'Double Punch' drug takes on advanced tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called SSGJ-709 in 15 people with advanced cancers that have spread. The drug is designed to block two immune system brakes (PD-1 and LAG-3) at once, potentially helping the body fight tumors. The main goals are to check safety and how…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New cancer drug JMT108 enters human testing
Disease control Recruiting nowThis early-phase trial is testing an experimental drug called JMT108, given alone or with other cancer drugs (pembrolizumab or ivonescimab), in people with advanced solid tumors who have run out of standard options. The main goals are to check safety, find the right dose, and get…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New smart drug TQB6411 targets two cancer proteins in early human trial
Disease control Recruiting nowThis Phase 1 trial tests TQB6411, an antibody-drug conjugate designed to bind to EGFR and c-Met proteins on tumor cells, blocking their growth signals and releasing a toxin to kill the cells. The study will enroll 216 adults with advanced malignant tumors to find the safest dose …
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC